• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LLC - HUNTINGTON ACRYSOF MULTIPIECE IOL; INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LLC - HUNTINGTON ACRYSOF MULTIPIECE IOL; INTRAOCULAR LENS Back to Search Results
Model Number MA60AC
Device Problem Material Opacification (1426)
Patient Problems Hemorrhage/Bleeding (1888); Hyphema (1911); Loss of Vision (2139)
Event Date 05/13/2019
Event Type  Injury  
Manufacturer Narrative
Complaint history and product history record could not be reviewed because the reporting facility did not provide a valid lot number or any identification traceable to the manufacturing documentation.Root cause has not been identified.Additional information has been requested.The manufacturer internal reference number is: (b)(4).
 
Event Description
A physician reported that following an intraocular lens implant procedure, the patient experienced a sudden vision loss, vitreous hemorrhage and total hyphema.The surgeon discontinued anticoagulants and performed a pars plana vitrectomy postoperatively.The surgeon reported the vitreous hemorrhage has cleared, but the patient has had a few "re-bleeds" following the vitrectomy procedure.The iol has also become opaque.The surgeon also suspects ugh (uveitis, glaucoma, hyphema) syndrome associated with the sulcus lens.Additional information has been received indicating the iol was exchanged for another lens.
 
Manufacturer Narrative
The product was returned for analysis.Investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.Results from the product history record review indicated the product met release criteria.There have been no other complaints reported in the lot number.The manufacturer internal reference number is: (b)(4).
 
Manufacturer Narrative
The lens was returned in a dry condition inside a small plastic sealed container.The anterior optic surface is adhered to the interior side wall of the container.Dried solution/matter was observed on the lens haptics and optic.The optic has two large areas of unknown, slightly opaque colored matter.One of these areas of matter is stretched across the anterior optic surface, extending onto one haptic.The other large area of matter is located on the posterior optic surface along the edge and stretching toward the optic center.The optic is scratched near the center.Three impressions similar to an instrument used to grasp a lens are observed on the optic edge leading inward, near the 12 0'clock position.A gouge/crack with the shape of an instrument used to grasp a lens is also observed near the 10 0'clock position of the optic edge leading inward.Very small particulate are also observed.The lens was cleaned with lphse for further evaluation.The unknown matter on the optic surface was removed easily with cleaning.Light scratches and small amount of tiny imbedded particulate were observed after cleaning.The lens material appears clear, post cleaning.The lens was allowed to air dry for a final evaluation.The lens material does not appear to be opaque.Product history records were reviewed and the documentation indicated the products met release criteria.The explanted lens pre-cleaning and post cleaning shows no signs of discoloration or opacification in the iol.The root cause cannot be determined for the complaint of "lens went opaque".The lens has damage and dried matter observed.The lens was cleaned and allowed to air dry.The lens appears clear after the removal of the solution and dried matter from the lens.It is unknown if the dried matter observed upon both sides of the optic was interpreted as the lens material becoming opaque.The head of global quality customer affairs & communications reviewed retro-illumination images of the lens while in the eye prior to the exchange which show uniform in color and intensity throughout the iol.The lens was explanted and returned.The head of global quality customer affairs & communications reviewed photos of the explanted returned lens in both a pre-cleaned and post cleaned state: images of the lens in a dry state prior to decontamination and cleaning show material located on the surface of the iol, noting that there was no signs of discoloration or opacification in the iol material.Images of the lens is a dry state post decontamination and cleaning show a clear iol with no signs of discoloration or opacification.The manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACRYSOF MULTIPIECE IOL
Type of Device
INTRAOCULAR LENS
Manufacturer (Section D)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
MDR Report Key8691472
MDR Text Key147773032
Report Number1119421-2019-00866
Device Sequence Number1
Product Code HQL
Combination Product (y/n)N
PMA/PMN Number
P930014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup,Followup
Report Date 09/13/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/31/2007
Device Model NumberMA60AC
Device Catalogue NumberMA60AC.215
Device Lot Number723387
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/08/2019
Initial Date Manufacturer Received 05/15/2019
Initial Date FDA Received06/12/2019
Supplement Dates Manufacturer Received06/26/2019
08/19/2019
Supplement Dates FDA Received07/20/2019
09/13/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age79 YR
-
-